Sexually Related Behaviors As Predictors of HPV Vaccination Among Young Rural Women

Overview

Journal J Womens Health (Larchmt)

Specialty Gynecology & Obstetrics

Date 2011 Dec 6

PMID 22136319

Citations 4

Authors

Laurel A Mills

Robin C Vanderpool

Richard A Crosby

Affiliations

Soon will be listed here.

Abstract

Purpose: To explore whether sexually related behaviors predict refusal of the human papillomavirus (HPV) vaccine among a sample of women aged 18-26 in Appalachian Kentucky.

Methods: Using a convenience sample, young women attending health clinics and a community college in southeastern Kentucky were recruited to participate in a Women's Health Study. After completing a questionnaire, women received a free voucher for the three-dose HPV vaccine series. Completion of dose one served as the outcome variable.

Results: Women with a history of an abnormal Pap test were almost two times more likely to decline the HPV vaccine (adjusted odds ratio [AOR] 1.91, 95% confidence interval [CI] 1.14-3.20, p=0.015), and women who reported they had never had a Pap test were four times more likely to decline the vaccine (AOR 4.02, 95% CI 1.13-14.32, p=0.032). Women engaging in mutual masturbation were nearly two times more likely to decline the free vaccine (AOR 1.91, 95% CI 1.17-3.10, p=0.009). Use of hormonal birth control showed a protective effect against refusal of the free HPV vaccine (AOR 0.593, 95% CI 0.44-0.80, p=0.001).

Conclusions: Among this sample of Appalachian women, those engaging in behaviors that increase their risk for HPV infection were more likely to refuse the vaccine. Conversely, those women engaging in protective health behaviors were more likely to accept the vaccine. These findings suggest that those women not being vaccinated may be the very group most likely to benefit from vaccination. Cervical cancer prevention programs need to be creative in efforts to reach young women most in need of the vaccine based on a higher profile of sexually related behaviors and the proxy measure of this risk (having an abnormal Pap test result).

Citing Articles

"1-2-3 Pap" Intervention Improves HPV Vaccine Series Completion among Appalachian Women.

Vanderpool R, Cohen E, Crosby R, Jones M, Bates W, Casey B J Commun. 2015; 63(1):95-115.

PMID: 26560123 PMC: 4639462. DOI: 10.1111/jcom.12001.

Effective dual method contraceptive use and HPV vaccination among U.S. adolescent and young adult females.

Vanderpool R, Williams C, Klawitter A, Eddens K Womens Health Issues. 2014; 24(5):543-50.

PMID: 25213746 PMC: 4758121. DOI: 10.1016/j.whi.2014.05.003.

Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination.

Brankovic I, Verdonk P, Klinge I Int J Equity Health. 2013; 12:14.

PMID: 23394214 PMC: 3598235. DOI: 10.1186/1475-9276-12-14.

Geographic variability in human papillomavirus vaccination among U.S. young women.

Wei F, Moore P, Green A Am J Prev Med. 2013; 44(2):154-7.

PMID: 23332332 PMC: 3552249. DOI: 10.1016/j.amepre.2012.09.061.

References

Markowitz L, Dunne E, Saraiya M, Lawson H, Chesson H, Unger E . Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(RR-2):1-24. View

Hopenhayn C, King J, Christian A, Huang B, Christian W . Variability of cervical cancer rates across 5 Appalachian states, 1998-2003. Cancer. 2008; 113(10 Suppl):2974-80. DOI: 10.1002/cncr.23749. View

Neubrand T, Breitkopf C, Rupp R, Breitkopf D, Rosenthal S . Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr (Phila). 2009; 48(9):966-9. DOI: 10.1177/0009922809337534. View

Friedman A, Shepeard H . Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav. 2006; 34(3):471-85. DOI: 10.1177/1090198106292022. View

Ishibashi K, Koopmans J, Curlin F, Alexander K, Friedman Ross L . Paediatricians' attitudes and practices towards HPV vaccination. Acta Paediatr. 2008; 97(11):1550-6. PMC: 2607063. DOI: 10.1111/j.1651-2227.2008.00958.x. View

Katz M, Reiter P, Heaner S, Ruffin M, Post D, Paskett E . Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine. 2009; 27(30):3945-52. PMC: 2700122. DOI: 10.1016/j.vaccine.2009.04.040. View

Behringer B, Friedell G . Appalachia: where place matters in health. Prev Chronic Dis. 2006; 3(4):A113. PMC: 1779277. View

Crosby R, Casey B, Vanderpool R, Collins T, Moore G . Uptake of free HPV vaccination among young women: a comparison of rural versus urban rates. J Rural Health. 2011; 27(4):380-4. PMC: 4753792. DOI: 10.1111/j.1748-0361.2010.00354.x. View

. Recommended adult immunization schedule: United States, 2010. Ann Intern Med. 2010; 152(1):36-9. DOI: 10.7326/0003-4819-152-1-201001050-00008. View

10.

Chao C, Slezak J, Coleman K, Jacobsen S . Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health. 2009; 99(6):1137-42. PMC: 2679804. DOI: 10.2105/AJPH.2008.147876. View

11.

Wingo P, Tucker T, Jamison P, Martin H, McLaughlin C, Bayakly R . Cancer in Appalachia, 2001-2003. Cancer. 2007; 112(1):181-92. DOI: 10.1002/cncr.23132. View

12.

Esposito S, Bosis S, Pelucchi C, Begliatti E, Rognoni A, Bellasio M . Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. Vaccine. 2007; 25(35):6437-46. DOI: 10.1016/j.vaccine.2007.06.053. View

13.

Raley J, Followwill K, Zimet G, Ault K . Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol. 2005; 12(3-4):127-33. PMC: 1784603. DOI: 10.1080/10647440400020661. View

14.

Keating K, Brewer N, Gottlieb S, Liddon N, Ludema C, Smith J . Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J Adolesc Health. 2008; 43(4 Suppl):S61-7. DOI: 10.1016/j.jadohealth.2008.06.015. View

15.

Zimet G, Mays R, Winston Y, Kee R, Dickes J, Su L . Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med. 2000; 9(1):47-50. DOI: 10.1089/152460900318957. View

16.

Herbert J, Coffin J . Reducing patient risk for human papillomavirus infection and cervical cancer. J Am Osteopath Assoc. 2008; 108(2):65-70. View

17.

Chao C, Velicer C, Slezak J, Jacobsen S . Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc. 2009; 84(10):864-70. PMC: 2755805. DOI: 10.4065/84.10.864. View

18.

Burchell A, Winer R, de Sanjose S, Franco E . Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006; 24 Suppl 3:S3/52-61. DOI: 10.1016/j.vaccine.2006.05.031. View

19.

. National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010. MMWR Morb Mortal Wkly Rep. 2011; 60(33):1117-23. View

20.

Brewer N, Fazekas K . Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007; 45(2-3):107-14. DOI: 10.1016/j.ypmed.2007.05.013. View